Preferred Label : Branchiootorenal syndrome 1;
Symbol : BOR1;
CISMeF acronym : BOR1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Melnick-fraser syndrome; Branchiootorenal dysplasia;
Description : Branchiootorenal syndrome is an autosomal dominant disorder characterized by sensorineural,
conductive, or mixed hearing loss, structural defects of the outer, middle, and inner
ear, branchial fistulas or cysts, and renal abnormalities ranging from mild hypoplasia
to complete absence. Reduced penetrance and variable expressivity has been observed
(Fraser et al., 1978). - Genetic Heterogeneity of Branchiootorenal Syndrome Approximately
40% of patients with BOR have mutations in the EYA1 gene. Mutations in the SIX5 gene
(600963) on chromosome 19q13 are found in about 5% of patients (BOR2; 610896). See
also branchiootic (BO) syndrome-1 (BOS1; 602588) and the otofaciocervical syndrome
(OFC; 166780), allelic disorders showing overlapping phenotypes but without renal
anomalies. See also 600257 for a discussion of the BOR-Duane-hydrocephalus contiguous
gene syndrome as described by Vincent et al. (1994). Although Melnick et al. (1978)
maintained that the BOR syndrome is distinct from the BO syndrome because in the latter
condition renal anomaly is absent and deafness is not a constant feature, Cremers
and Fikkers-van Noord (1980) concluded that the 2 syndromes are in fact a single entity.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the EYA transcriptional coactivator and phosphatase 1 gene (EYA1,
601653.0001);
Prefixed ID : #113650;
Origin ID : 113650;
UMLS CUI : C4551702;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT